Patents by Inventor Jean-Luc Guesdon

Jean-Luc Guesdon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9868989
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: January 16, 2018
    Assignee: INSTITUT PASTEUR
    Inventors: Christine Petit, Francoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin, Jean-Luc Guesdon
  • Publication number: 20160076101
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Application
    Filed: September 18, 2015
    Publication date: March 17, 2016
    Applicant: Institut Pasteur
    Inventors: Christine Petit, Francoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin, Jean-Luc Guesdon
  • Patent number: 9169517
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: October 27, 2015
    Assignee: INSTITUT PASTEUR
    Inventors: Christine Petit, Francoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin, Jean-Luc Guesdon
  • Publication number: 20140113285
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Application
    Filed: May 22, 2013
    Publication date: April 24, 2014
    Applicants: Centre National de la Recherche Scientifique, Institut Pasteur
    Inventors: Christine PETIT, Francoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin-Duvernois, Jean-Luc Guesdon
  • Patent number: 8455195
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: June 4, 2013
    Assignee: Institut Pasteur
    Inventors: Christine Petit, Françoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin-Duvernois, Jean-Luc Guesdon
  • Publication number: 20120322059
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Application
    Filed: March 26, 2012
    Publication date: December 20, 2012
    Applicant: Institut Pasteur
    Inventors: Christine Petit, Françoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin-Duvernois, Jean-Luc Guesdon
  • Patent number: 8143000
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: March 27, 2012
    Assignee: Institut Pasteur
    Inventors: Christine Petit, Françoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin-Duvernois, Jean-Luc Guesdon
  • Publication number: 20090104600
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Application
    Filed: July 12, 2007
    Publication date: April 23, 2009
    Inventors: Christine Petit, Francoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin-Duvernois, Jean-Luc Guesdon
  • Patent number: 7258975
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in wildtype form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: August 21, 2007
    Assignee: Institut Pasteur
    Inventors: Christine Petit, Françoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin-Duvernois, Jean-Luc Guesdon
  • Publication number: 20030170676
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Application
    Filed: October 23, 2002
    Publication date: September 11, 2003
    Applicant: Institute Pasteur
    Inventors: Christine Petit, Francoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin-Duvernois, Jean-Luc Guesdon
  • Patent number: 6485908
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in wild-type form encodes a polypeptide implicated in hereditary sensory defect, wherein the mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Grant
    Filed: May 3, 2000
    Date of Patent: November 26, 2002
    Assignee: Institut Pasteur
    Inventors: Christine Petit, Françoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin-Duvernois, Jean-Luc Guesdon
  • Patent number: 5998147
    Abstract: A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild type form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.
    Type: Grant
    Filed: August 14, 1998
    Date of Patent: December 7, 1999
    Assignee: Institut Pasteur
    Inventors: Christine Petit, Francoise Denoyelle-Gryson, Dominique Weil, Sandrine Marlin-Duvernois, Jean-Luc Guesdon
  • Patent number: 5998138
    Abstract: The present invention relates to a nucleic acid sequence isolated from C. coli which hybridizes specifically with the genomic nucleic acid of strains belonging to the species C. coli and which does not hybridize under the usual conditions with the nucleic acids of campylobacteria which do not belong to this species, nor with the genomic nucleic acids of bacteria related to the genus Campylobacter.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: December 7, 1999
    Assignee: Institut Pasteur
    Inventors: Veronique Stonnet, Jean-Luc Guesdon
  • Patent number: 5955262
    Abstract: Method for detecting the possible presence of a DNA fragment, notably of a gene, in the midst of a complex sample of nucleic acids.It comprises the hybridization of the sought fragment with a RNA probe, this being, prior or subsequent to the hybridization reaction, modified by an enzyme.Application to seeking of particular genes or DNA fragments in the midst of a biological sample.
    Type: Grant
    Filed: September 8, 1992
    Date of Patent: September 21, 1999
    Assignee: Institut Pasteur
    Inventors: Philippe Kourilsky, Stratis Avrameas, Brigitte Cami Contamine, Jean-Luc Guesdon
  • Patent number: 5876928
    Abstract: Method for detecting the possible presence of a DNA fragment, notably of a gene, in the midst of a complex sample of nucleic acids.It comprises the hybridization of the sought fragment with a RNA probe, this being, prior or subsequent to the hybridization reaction, modified by an enzyme.Application to seeking of particular genes or DNA fragments in the midst of a biological sample.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 2, 1999
    Assignee: Institut Pasteur
    Inventors: Philippe Kourilsky, Stratis Avrameas, Brigitte Cami, born Contamine, Jean-Luc Guesdon
  • Patent number: 5837455
    Abstract: Fragments of nucleic acids derived from an appropriate mycobacteria genome, particularly Mycobacterium tuberculosis, their applications in the diagnosis of mycobacteria infections, as well as plasmides containing said fragments. The nucleotidic sequence is comprised of a nucleotidic sequence repeated in the genome of a mycobacterium and specific of the bacillus of tuberculosis and is characterized by a strong hybridation with M. tuberculosis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 17, 1998
    Assignee: Institut Pasteur
    Inventors: Jean-Luc Guesdon, Dominique Thierry, Agnes Ullmann, Brigitte Gicquel, Anne Brisson-Noel
  • Patent number: 5807672
    Abstract: Fragments of nucleic acids derived from an appropriate mycobacteria genome, particularly Mycobacterium tuberculosis, their applications in the diagnosis of mycobacteria infections, as well as plasmides containing said fragments. The nucleotidic sequence is comprised of a nucleotidic sequence repeated in the genome of a mycobacterium and specific of the bacillus of tuberculosis and is characterized by a strong hybridation with M. tuberculosis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 15, 1998
    Assignee: Institut Pasteur
    Inventors: Jean-Luc Guesdon, Dominique Thierry, Agnes Ullman, Brigitte Gicquel, Anne Brisson-Noel
  • Patent number: 5776693
    Abstract: The invention relates to a nucleic acid fragment derived from the Mycobacterium tuberculosis genome, characterized in that it contains one of the sequences I, II, III and IV, defined in the following manner:I: a sequence chosen from one of the sequences A to H:A: 5'-CCCGCGGCAAAGCCCGCAGGACCACGATCG-3' (SEQ ID NO. 1)B: 5'-CGACCCGCCAGCCCAGGATCCTGCGAGCGT-3' (SEQ ID NO. 2)C: 5'-GGCGGGTCCAGATGGCTTGCTCGATCGCGT-3' (SEQ ID NO. 3)D: 5'-GTTGGCGGGTCCAGATGGCTTGCTCGATCG-3' (SEQ ID NO. 4)E: 5'-TCAAAGGGTTTGACAAATTAATGATTGGTC-3' (SEQ ID NO. 5)F: 5'-TCGTGTACAAAATGTGGACAAGTA-3' (SEQ ID NO. 6)G: 5'-TCGACGGACGTCGTGACCAGAAGTC-3' (SEQ ID NO. 7)H: 5'-GTCGACACGCCTTCTGCACGGGAAGTCCTT-3' (SEQ ID NO.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: July 7, 1998
    Assignee: Institut Pasteur
    Inventors: Jean-Luc Guesdon, Dominique Thierry
  • Patent number: 5691138
    Abstract: The subject of the present invention is thus a nucleotide sequence which hybridizes specifically with a Campylobacter jejuni genomic nucleic acid sequence chosen from the nucleotide sequence SEQ ID No. 1, the nucleotide sequence SEQ ID No. 2 the sequences complementary to the latter, as well as the sequences differing therefrom by nutation, insertion, deletion or substitution of one or more bases, and which does not or virtually does not hybridize with nucleic acids from other Campylobacter species.Fragments of this sequence can be used as specific primers for the amplification of sequences specific for Campylobacter jejuni and as nucleic probes specific for Campylobacter jejuni nucleic sequences.The subject of the invention is also a method of detecting the presence of Campylobacter jejuni stains in a biological sample, as well a kit for carrying out the method.
    Type: Grant
    Filed: September 29, 1994
    Date of Patent: November 25, 1997
    Assignee: Institut Pasteur
    Inventors: Jean-luc Guesdon, Veronique Stonnet
  • Patent number: 5650272
    Abstract: A nucleic acid sequence which specifically hybridizes with a genomic nucleic acid sequence of strains of the complex Mycobacterium avium-intracellulare selected from nucleotide sequence SEQ ID No 1, nucleotide sequence SEQ ID No 2, complementary sequences thereof, and sequences differing therefrom by the mutation, insertion, deletion or substitution of one or more bases, but does not hybridize with the nucleic acids of mycobacteria which do not belong to said complex. Fragments of the sequence may be used as primers for amplifying sequences which are specific for strains of the complex Mycobacterium avium-intracellulare, and as nucleic probes which are specific for nucleic sequences of strains of the complex Mycobacterium avium-intracellulare. A method for detecting strains of the complex Mycobacterium avium-intracellulare in a biological sample, and a kit for implementing the method, are also provided.
    Type: Grant
    Filed: May 2, 1994
    Date of Patent: July 22, 1997
    Assignee: Institut Pasteur
    Inventors: Jean-Luc Guesdon, Dominique Thierry, Veronique Vincent